Patient engagement in melanoma research: from bench to bedside.
PPI
advocacy
clinical trial
melanoma
patient engagement
research
risk
Journal
Future oncology (London, England)
ISSN: 1744-8301
Titre abrégé: Future Oncol
Pays: England
ID NLM: 101256629
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
pubmed:
3
7
2021
medline:
8
2
2022
entrez:
2
7
2021
Statut:
ppublish
Résumé
Advances in research have transformed the management of melanoma in the past decade. In parallel, patient advocacy has gained traction, and funders are increasingly prioritizing patient and public involvement. Here we discuss the ways in which patients and the public can be engaged in different stages of the research process, from developing, prioritizing and refining the research question to preclinical studies and clinical trials, then finally to ongoing research in the clinic. We discuss the challenges and opportunities that exist at each stage in order to ensure that a representative population of patients and the public contribute to melanoma research both now and in the future.
Identifiants
pubmed: 34213356
doi: 10.2217/fon-2020-1165
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM